A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

China

Peking Union Medical College Hospital, Beijing, Beijing Municipality

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

Union Hospital Tongji Medical College Huazhong University of Science And Technology, Wuhan, Hubei

Shandong Cancer Hospital, Jinan, Shandong

Shanghai Changhai Hospital, Shanghai, Shanghai Municipality

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Zhejiang Provincial People's hospital, Hangzhou, Zhejiang